Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Intervalo de año de publicación
1.
Chem Biodivers ; 17(2): e1900414, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31797547

RESUMEN

Protein tyrosine phosphatases are involved in diverse human diseases, including cancer, diabetes and inflammatory disorders. Loss of Vaccinia-H1 related phosphatase (VHR) has been shown to arrest at the G1-S and G2-M transitions of the cell cycle, and to increases cell death of prostate cancer cells through JNK activation, suggesting that VHR can be considered as an anticancer target. In this study, 658 natural products were screened through in vitro enzyme assay to identify VHR inhibitor. Among the VHR-inhibitory compounds, 1,2,3,4,6-O-pentagalloylglucose (PGG) was selected for further study as it has been reported to show antitumor effects against tumor model mice, but its direct target has not been identified. PGG inhibited the catalytic activity of VHR (Ki =53 nm) in vitro. Furthermore, the incubation of HeLa cervical cancer cells with PGG dramatically decreased cell viability and markedly increased the protein levels of the cleaved PARP, a hallmark of apoptosis. In addition, treatment of HeLa cells with PGG significantly reduced the protein levels of cyclin D1, Bcl-2 and STAT3 phosphorylation. Taken together, these results suggest that PGG could be a potential therapeutic candidate for the treatment of cervical cancer through VHR inhibition.


Asunto(s)
Antineoplásicos/química , Fosfatasa 3 de Especificidad Dual/antagonistas & inhibidores , Taninos Hidrolizables/química , Antineoplásicos/metabolismo , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Ciclina D1/genética , Ciclina D1/metabolismo , Regulación hacia Abajo/efectos de los fármacos , Fosfatasa 3 de Especificidad Dual/genética , Fosfatasa 3 de Especificidad Dual/metabolismo , Células HeLa , Humanos , Taninos Hidrolizables/metabolismo , Taninos Hidrolizables/farmacología , Cinética , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo
2.
Artículo en Coreano | WPRIM (Pacífico Occidental) | ID: wpr-786611

RESUMEN

Infectious diseases of the upper gastrointestinal tract are rare, but certain bacteria including Treponema pallidum and Mycobacterium tuberculosis may infect the esophagus, stomach, and duodenum even in an immunocompetent individual. Gastric syphilis is difficult to diagnose because it presents with non-specific symptoms and diverse endoscopic findings. Nevertheless, gastric syphilis should be considered in the differential diagnosis when a patient presents with chronic inflammatory gastric lesions such as multiple erosive/ulcerative lesions and stricture or with other evidence of syphilis. Histological evaluation and specific serological tests should be performed if syphilis is suspected. Esophageal and gastroduodenal tuberculosis also exhibits non-specific clinical manifestations. The diagnosis is confirmed by mucosal biopsy or aspiration cytology revealing the presence of caseating granulomata and/or acid-fast bacilli. Mycobacterial culture and polymerase chain reaction should be incorporated into routine diagnostic studies to improve the diagnostic sensitivity. The diagnosis of tuberculosis is occasionally confirmed indirectly by an excellent response of the patient to anti-tubercular therapy.


Asunto(s)
Humanos , Bacterias , Biopsia , Enfermedades Transmisibles , Constricción Patológica , Diagnóstico , Diagnóstico Diferencial , Duodeno , Esófago , Mycobacterium tuberculosis , Reacción en Cadena de la Polimerasa , Pruebas Serológicas , Estómago , Sífilis , Treponema pallidum , Tuberculosis , Tracto Gastrointestinal Superior
3.
Clinical Endoscopy ; : 256-259, 2015.
Artículo en Inglés | WPRIM (Pacífico Occidental) | ID: wpr-178046

RESUMEN

Syphilis is a chronic systemic infectious disease caused by the bacterium Treponema pallidum. Gastric involvement and nephrotic syndrome are uncommon but well documented complications of syphilis, but the co-occurrence of these two complications in the same patient is extremely rare. Thus, because of their nonspecific presentation, suspicion of gastric syphilis (GS) and nephrotic syndrome is essential for diagnosis. Patients should be investigated thoroughly and a diagnosis made based on clinical, endoscopic, and histological findings, in order to initiate appropriate therapy. We report of a 34-year-old male patient with a history of epigastric pain and a diagnosis of GS and syphilis-associated membranous glomerulonephritis confirmed by gastroscopy and kidney biopsy, who was treated successfully with penicillin G benzathine. This case report provides information on the typical features of GS that should help raise awareness of this rare disease entity among clinicians, resulting in earlier diagnosis and administration of appropriate therapy.


Asunto(s)
Adulto , Humanos , Masculino , Biopsia , Enfermedades Transmisibles , Diagnóstico , Gastroscopía , Glomerulonefritis Membranosa , Riñón , Síndrome Nefrótico , Penicilina G Benzatina , Enfermedades Raras , Estómago , Sífilis , Treponema pallidum
4.
The Ewha Medical Journal ; : S33-S36, 2014.
Artículo en Inglés | WPRIM (Pacífico Occidental) | ID: wpr-126662

RESUMEN

The major risk factors of hepatocellular carcinoma include hepatitis B or C virus infection and alcohol consumption in Korea which lead to liver cirrhosis development and progression. However, prevalence of non-alcoholic fatty liver disease related hepatocellular carcinoma is rising worldwide and hepatocellular carcinoma cases in patients with non-cirrhotic non-alcoholic steatohepatitis are increasing. A hypoechoic nodule was incidentally detected in a 52-year-old woman, with no evidence of liver cirrhosis or specific hepatocellular carcinoma findings on radiological examination. Non-cirrhotic non-alcoholic steatohepatitis-associated hepatocellular carcinoma was diagnosed based on clinical, laboratory, and histopathological findings of liver biopsy. To our knowledge, this is the first such case report in Korea.


Asunto(s)
Femenino , Humanos , Persona de Mediana Edad , Consumo de Bebidas Alcohólicas , Biopsia , Carcinoma Hepatocelular , Hígado Graso , Hepatitis B , Corea (Geográfico) , Hígado , Cirrosis Hepática , Prevalencia , Factores de Riesgo
5.
Artículo en Inglés | WPRIM (Pacífico Occidental) | ID: wpr-119488

RESUMEN

BACKGROUND/AIMS: The incidence of symptomatic hepatitis A reportedly increased among 20- to 40-year-old Korean during the late 2000s. Vaccination against hepatitis A was commenced in the late 1990s and was extended to children aged <10 years. In the present study we analyzed the changes in the seroprevalence of IgG anti-hepatitis A virus (HAV) over the past 13 years. METHODS: Overall, 4903 subjects who visited our hospital between January 2001 and December 2013 were studied. The seroprevalence of IgG anti-HAV was analyzed according to age and sex. In addition, the seroprevalence of IgG anti-HAV was compared among 12 age groups and among the following time periods: early 2000s (2001-2003), mid-to-late 2000s (2006-2008), and early 2010s (2011-2013). The chi-square test for trend was used for statistical analysis. RESULTS: The seroprevalence of IgG anti-HAV did not differ significantly between the sexes. Furthermore, compared to the seroprevalence of IgG anti-HAV in the early 2000s and mid-to-late 2000s, that in the early 2010s was markedly increased among individuals aged 1-14 years and decreased among those aged 25-44 years (P<0.01). We also found that the seroprevalence of IgG anti-HAV in individuals aged 25-44 years in the early 2010s was lower than that in the early 2000s and mid-to-late 2000s. CONCLUSIONS: The number of symptomatic HAV infection cases in Korea is decreasing, but the seroprevalence of IgG anti-HAV is low in the active population.


Asunto(s)
Adolescente , Adulto , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Adulto Joven , Factores de Edad , Hepatitis A/diagnóstico , Anticuerpos de Hepatitis A/análisis , Virus de la Hepatitis A/inmunología , Inmunoglobulina G/análisis , República de Corea , Estudios Seroepidemiológicos , Factores Sexuales
6.
Korean Journal of Medicine ; : 432-437, 2010.
Artículo en Coreano | WPRIM (Pacífico Occidental) | ID: wpr-120827

RESUMEN

Multiple Endocrine Neoplasia Type 2 (MEN2) is a rare hereditary complex disorder characterized by the presence of medullary thyroid carcinoma, pheochromocytoma, and other hyperplasias or neoplasias of different endocrine tissues within a single patient. Simultaneous occurrence of MEN2 and other cancers that are derived from different origins is rare. In this report, we present a patient with known MEN2 who developed breast cancer as a result of invasive ductal carcinoma. The patient underwent total thyroidectomy and unilateral adrenalectomy due to medullary thyroid cancer and pheochromocytoma. Although patients with MEN2 may demonstrate a variety of neoplastic disorders, it is difficult to identify a case report of MEN2 with breast cancer. In addition, no etiological relationships between breast cancer and MEN2 have been reported to date. Thus, here we report a case of known MEN2 with breast cancer and present a review of the literature.


Asunto(s)
Humanos , Adrenalectomía , Mama , Neoplasias de la Mama , Carcinoma Ductal , Hiperplasia , Neoplasia Endocrina Múltiple , Neoplasia Endocrina Múltiple Tipo 2a , Feocromocitoma , Proteínas Proto-Oncogénicas c-ret , Neoplasias de la Tiroides , Tiroidectomía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...